levothyroxine

(redirected from Euthyrox)
Also found in: Dictionary, Wikipedia.

levothyroxine

 [le″vo-thi-rok´sin]
l-thyroxine, obtained from the thyroid gland of domesticated food animals or prepared synthetically; used for replacement therapy in hypothyroidism and for the prophylaxis and treatment of goiter and of thyroid cancer; administered orally, intravenously, or intramuscularly as the sodium salt.

levothyroxine

/le·vo·thy·rox·ine/ (le″vo-thi-rok´sēn) -thyroxine, obtained from the thyroid gland of domesticated food animals or prepared synthetically; used as the sodium salt in the treatment of hypothyroidism and the treatment and prophylaxis of goiter and thyroid carcinoma.

levothyroxine

(lē′və-thī-rŏk′sēn′, -sĭn)
n.
An isomer of thyroxine, C15H10I4NO4, used in the form of its sodium salt to treat thyroxine deficiency.

levothyroxine

Thyroid hormone as a sodium salt used to treat hypothyroidism. The drug is on the WHO official list. A brand name is Thyronine.

levothyroxine

the pharmaceutical name for the thyroid hormone thyroxine (T4); used for replacement therapy in hypothyroidism.
References in periodicals archive ?
Through transfer of knowledge, we will have the technical capabilities to produce more complex medicines, such as hormone therapies like Merck's Euthyrox.
The new facility, which will be the Group s second-largest pharmaceutical manufacturing facility worldwide, will focus on the bulk production and packaging of Glucophage, Concor and Euthyrox, Merck Serono s leading brands for the treatment of diabetes, cardiovascular diseases and thyroid disorders, respectively.
A spokesman for Gulf Pharmacy said all drug shortages had been resolved except for Euthyrox, a thyroid medication supplied by Merck.
The two products to be produced at Neopharma's facilities are Euthyrox, a synthetic thyroid hormone and Glucophage, for people suffering from type 2 diabetes.
Initially, two Merck Serono products will be manufactured by Neopharma: Euthyrox, a hormone therapy requiring a very stringent sterile environment for production and packaging; and Glucophage a standard oral treatment for people suffering from type 2 diabetes that helps control blood sugar levels.
Completion of the facility, which will focus on bulk production and packaging of Glucophage, Concor and Euthyrox, is scheduled for 2016, with commercial production starting in 2017.
This latest facility will concentrate on massive manufacturing and wrapping of Glucophage, Concor and Euthyrox, Merck s brands used for treatment of diabetes, cardiovascular diseases and thyroid disorders correspondingly.
Under the agreement, initially, Neopharma will manufacture two Merck Serono products, namely Euthyrox, a hormone therapy requiring a very stringent sterile environment for production and packaging, and Glucophage a standard oral treatment for people suffering from type 2 diabetes that helps control blood sugar levels.